← All trials
NCT02434952
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2014
- Primary completion
- Jul 1, 2016
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 109
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Malaria ConsortiumLead sponsor
- National Centre for Parasitology, Entomology and Malaria Control, CambodiaCollaborator
- National Centre for Parasitology, Entomology and Malaria Control, CambodiaOverall official - principal investigator
- World Health OrganizationCollaborator
- Institut PasteurCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.